Home | Careers | Contact Us Diagnostics Diagnostics Overview BioReference Laboratories OPKO Lab Point-of-Care Diagnostics Platform Therapeutics Therapeutics Overview Renal Biologics OPKO-CURNA Protein-Based Vaccines Asthma & COPD Parkinson’s Disease CINV Products Overview OPKO Chile OPKO EU OPKO FineTech OPKO Mexico OPKO Mexico Privacy Policy / Aviso de Privacidad EirGen Pharma Strategic Investments Strategic Investments Overview Investor Relations Press Releases Conferences & Events Corporate Governance SEC Filings Stock Performance Investor Faq Email Alerts 2014 Annual Report 2015 Proxy Statement Forms 8937 OPKO Health Inc. BioReference Laboratories Inc. PROLOR Biotech Inc. About Us Company Overview Management Team Board of Directors Scientific Advisory Board Careers Contact Us Biomarker Discovery Team OPKO Careers OPKO Chile OPKO-CURNA OPKO Diagnostics OPKO EU OPKO FineTech OPKO Mexico Transformative Diagnostics Next-Generation Therapies & Vaccines Addressing large, unmet global markets with innovative proprietary products More » Worldwide Production & Distribution Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More » Strategic Investments Identifying early-stage companies with potential to increase value for shareholders More » Chairman’s Message OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors and I would like to review several highlights. OPKO Completes Acquisition of Bio-Reference Laboratories. OPKO Letter to Shareholders» News & Events more news » Oct. 1, 2015 Conversion Right Extended on OPKO 3.0% Convertible Senior Notes more » Sep.22, 2015 OPKO Health to Present at the Ladenburg Thalmann 2015 Healthcare Conference more » Sep. 9, 2015 OPKO Health Announces Global License Agreement for the Discovery of Novel Antimicrobials more » Investors read more » OPKO Health is an opportunistic research and development company that targets large, high-growth markets. Former shareholders of Bio-Reference Laboratories, Inc. that have questions related to the exchange of BRLI shares to OPK shares, please contact our exchange agent, American Stock Transfer & Trust Company, LLC, toll free at (877) 248-6417 or (718) 921-8317. © 2014 OPKO Health Inc.- All rights reserved. Contact Us Privacy Policy Terms Of Use